Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Aurinia Pharmaceuticals Inc. (AUPH) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $12.79 Metrics
OS: 143.4 M
Market cap: $1.83 B
Net cash: $432 M $3.01 per share
EV: $1.4 B

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
Revenues134.045.650.10.30.50.40.2
            Revenue growth193.9%-9.0%15660.4%-31.3%10.8%141.6% 
Cost of goods sold5.71.10.00.00.047.325.2
Gross profit128.444.550.10.30.5-46.9-25.0
            Gross margin95.8%97.6%100.0%100.0%100.0%-11212.4%-14466.5%
Selling, general and administrative     -0.22.2
Research and development45.051.150.352.941.4  
General and administrative196.4173.597.322.313.7  
EBITA-109.4-178.6-103.0-89.8-53.9-46.7-27.3
            EBITA margin-81.6%-391.7%-205.5%-28240.6%-11651.6%-11170.8%-15758.4%
Amortization of intangibles2.12.11.31.11.3  
EBIT-111.5-180.7-104.3-90.9-55.2-46.7-27.3
            EBIT margin-83.2%-396.3%-208.1%-28598.4%-11930.9%-11170.8%-15758.4%
Pre-tax income-106.4-180.2-102.8-88.2-53.0-70.8-23.3
Income taxes1.80.8-0.10.10.10.00.0
            Tax rate  0.1%  0.0%0.0%
Net income-108.2-181.0-102.7-88.4-53.1-70.8-23.3
            Net margin-80.7%-396.8%-204.9%-27794.0%-11464.1%-16935.9%-13465.3%
 
Diluted EPS($0.76)($1.40)($0.87)($0.95)($0.63)($0.92)($0.66)
Shares outstanding (diluted)141.9129.4118.593.084.876.935.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy